Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 3/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPC1L1 | Q9UHC9 | 6/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.40 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.38 |
| ▸ | DRD5 | P21918 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5780785 | 0.93 | OPRM1 (0.41) | OPRL1OPRM1OPRK1CYP3A4CYP2D6 | |
| SCHEMBL5783117 | 0.86 | OPRM1 (0.47) | OPRL1OPRM1OPRK1NPC1L1OPRD1 | |
| SCHEMBL5783032 | 0.85 | NPC1L1 (0.44) | OPRL1OPRM1OPRK1NPC1L1OPRD1 | |
| SCHEMBL6483719 | 0.85 | OPRL1 (0.48) | OPRL1OPRM1OPRK1NPC1L1OPRD1 | |
| SCHEMBL5799770 | 0.83 | OPRM1 (0.41) | OPRL1OPRM1OPRK1CYP3A4CYP2D6 | |
| SCHEMBL6481297 | 0.83 | NPC1L1 (0.50) | OPRL1OPRM1OPRK1NPC1L1 | |
| SCHEMBL5782590 | 0.83 | ENPP2 (0.46) | OPRL1OPRM1OPRK1NPC1L1OPRD1 | |
| SCHEMBL5779643 | 0.82 | OPRL1 (0.43) | OPRL1OPRM1OPRK1CYP3A4CYP2D6 | |
| SCHEMBL6474755 | 0.82 | ENPP2 (0.44) | OPRL1OPRM1OPRK1CYP3A4CYP2D6 | |
| SCHEMBL6473614 | 0.82 | OPRL1 (0.42) | OPRL1OPRM1OPRK1CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6919349-B2 | Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient | TORAY INDUSTRIES, INC. (JP) | 2005-07-19 | — | — | US | disclosed |
| US-20040087574-A1 | Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient | TORAY INDUSTRIES INC. (JP) | 2004-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040087574-A1 | Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient | VCAM1, ICAM1, SELL | OPRL1 738/4885OPRM1 2044/4885OPRK1 1419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.